Tag Archives: Boehringer Ingelheim

Exosomes start to deliver deals

exosomes

Some biotech investors had probably never heard of exosomes until Codiak’s chief executive, Doug Williams, made his pitch at the JP Morgan conference two weeks ago. But the area has been gaining traction, and Jazz’s $56m up-front...

Read More »